ExploreWatchlistsPricing
  1. JP-listed companies
  2. Japan Tissue Engineering Co., Ltd.
  3. Financials
  4. Net income margin (%)

Japan Tissue Engineering Co., Ltd. (7774)

Market cap
¥24.7B
P/E ratio
-45.6x
Develops and manufactures regenerative medicine products that restore tissue function by culturing patients' own cells for transplantation.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndNet income margin (%) YoY (%)
Mar 31, 2025-10.4-282.59%
Mar 31, 20245.7-115.87%
Mar 31, 2023-35.9+51.60%
Mar 31, 2022-23.7+14.52%
Mar 31, 2021-20.7+66.29%
Mar 31, 2020-12.4-12.06%
Mar 31, 2019-14.1-240.87%
Mar 31, 201810-22.46%
Mar 31, 201712.9-127.16%
Mar 31, 2016-47.6-8.84%
Mar 31, 2015-52.3-36.37%
Mar 31, 2014-82.1-57.04%
Mar 31, 2013-191.2-17.41%
Mar 31, 2012-231.5

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat